# Enoxaparin Metabolism in Reconstructive Surgery Patients

> **NCT02411292** · PHASE2 · COMPLETED · sponsor: **University of Utah** · enrollment: 110 (actual)

## Conditions studied

- Venous Thromboembolism
- Deep Venous Thrombosis
- Pulmonary Embolus
- Reconstructive Surgery

## Interventions

- **DRUG:** Enoxaparin

## Key facts

- **NCT ID:** NCT02411292
- **Lead sponsor:** University of Utah
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-03
- **Primary completion:** 2016-03
- **Final completion:** 2016-06
- **Target enrollment:** 110 (ACTUAL)
- **Last updated:** 2018-11-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02411292

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02411292, "Enoxaparin Metabolism in Reconstructive Surgery Patients". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02411292. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*